microbicide. Adaptation to formulated benzalkonium chloride in particular was more likely to 48 increase antibiotic susceptibility than the simple aqueous solution. In conclusion, bacterial 49 adaptation through repeated microbicide-exposure was associated with both increases and 50 decreases in antibiotic susceptibility. Formulation of the microbicide to which the bacteria had 51 previously adapted had an identifiable effect on antibiotic susceptibility but this was typically 52 small relative to the differences observed among microbicides. Susceptibility changes 53 resulting in resistance were not observed. The safety of certain microbicide applications has been questioned due to the possibility microbicide 57 exposure could select for microbicide and antibiotic resistance. Evidence that this may happen is based 58 mainly on in vitro experiments where bacteria have been exposed to microbicides in aqueous solution. 59
Microbicides are however normally deployed in products formulated with surfactants, sequestrants 60 and other compounds. Whilst this may influence the frequency and extent of susceptibility changes, 61 few reports in the literature have assessed this. In the current investigation therefore we have 62
investigated changes in antibiotic susceptibility in bacteria, which exhibited decreased microbicide 63 susceptibility following repeated exposure to microbicides in simple aqueous solutions and in 64
formulation. We report that microbicide formulation had an identifiable effect on antibiotic 65 susceptibility but this was typically small relative to the differences observed among microbicides. 66
Susceptibility changes resulting in resistance were not observed. 67
INTRODUCTION 70
Microbicides are broad-spectrum antimicrobial compounds that are widely deployed to 71 control the growth of microorganisms or eliminate them. Applications include the control of 72 biofouling and microbial contamination in industry (1) as well as clinical antisepsis (2) (3) (4) . 73 They are also used extensively in the domestic environment as hygiene adjuncts and 74 preservatives in a range of formulations including oral care products (5), hand sanitizers (6) 75 and hard surface cleaners (7) . 76 The safety of certain microbicide applications has been questioned due to the possibility that 77 long-term microbicide exposure could select for reduced antimicrobial susceptibility in 78 bacteria (8-10). Reduced microbicide susceptibility has been reported for some combinations 79 of bacterium and microbicide (11) and changes in bacterial susceptibility to chemically 80 unrelated antimicrobials such as antibiotics or other microbicides have been reported 81 following laboratory microbicide exposure (12, 13) . The mechanisms involved in such cross-82 resistance include selection for mutations in shared cellular target sites, upregulation of efflux 83 pumps (14), reductions in cell permeability (15) and in some cases, sporulation (16).
84
Evidence that microbicides can select for reduced microbicide susceptibility in the 85 environment is limited, with the majority of reports relating to in vitro exposure (17) in an aerobic incubator. After incubation, growth observed at the highest microbicide 157 concentration was aseptically removed and streaked onto a fresh plate containing the same 158 antimicrobial compound concentration gradient. Where growth was observed across the 159 whole antimicrobial gradient, a new plate produced with a 5-fold-higher microbicide 160 concentration was used. This process was repeated until 14 passages had occurred (P14).
161
Bacteria at P0 and P14 were archived for subsequent susceptibility testing. environments were superior to all others tested (lowest Akaike information criterion). To 183 account for the fact that closely related bacteria are likely to respond more similarly than 184 others just through having a more recent common ancestor, a correlation term was included 185 based on the 16S-based phylogenetic tree of the strains used. Testing different weightings on 186 this correlation term (Pagel's λ (29) ) determined that a Brownian model (i.e. Pagel's λ = 1) 187 was best. In addition, a LMM was fitted for the subset of data involving microbicides where 188 bacteria were tested that had adapted to both formulated and unformulated versions of the 189 microbicidal environment. In this case, accounting for non-homogenous variance was best 190 done by allowing different variances for different microbicidal environments and for variance 191 to increase at higher values according to the formula e (0.65 * zone of clearance value) . All models were 192 fitted using the NLME package (Version 3.1) (30) in R version 3.2 (31) with phylogenetic 193 correlation structures created using the APE package (version 3.3) (32). Where p-values are 194 not explicitly given, statistical significance was deemed to be p< 0·05.
195

RESULTS
196
After exposure to microbicides in simple aqueous solution, out of 90 possible combinations of 197 bacterium and antibiotic, 22% significantly (P < 0.05) reduced in antibiotic susceptibility (8% 198 towards ciprofloxacin, 6% to ampicillin, 4% to kanamycin, 2% to tetracycline and 2% to 199 cephalothin). In comparison, 20% significantly increased in antibiotic susceptibility (6% 200 towards ciprofloxacin, 4% to kanamycin, 4% to tetracycline, 3% to cephalothin and 2% to 201 ampicillin). After exposure to the formulated microbicides, out of 50 possible combinations of 202 bacterium and antibiotic, 22% significantly decreased in antibiotic susceptibility (6% 203 ciprofloxacin, 6% kanamycin, 4% cephalothin and 4% tetracycline and 2% ampicillin). In 204 comparison, 12% significantly increased in antibiotic susceptibility (8% ciprofloxacin 2% 205 kanamycin and 2% tetracycline). Importantly, whilst statistically significant increases and 206 decreases in antibiotic susceptibility occurred, generation of resistance as defined by BSAC 207 breakpoints was not observed in any previously susceptible bacterium.
208
The frequency of reduction in antibiotic susceptibility was highest in organisms exhibiting 209 previously reduced susceptibility towards DMDM hydantoin (80%), followed by BAC, CHX, 210 DDAC (20%), triclosan (20%) and PHMB (16%). Bacteria with reduced susceptibility to 211 triclosan showed the highest frequency of increased antibiotic susceptibility (45%), followed 212 by CHX (30%), DDAC (27%), DMDM hydantoin (20%) and PHMB (4%). In comparison, 213 after exposure to the formulations, 27% of thymol formulation and 20% of DDAC there was a significant decrease in susceptibility of S. aureus to ciprofloxacin and kanamycin 220 (Table 1) . E. coli also showed a significant reduction in kanamycin susceptibility after 221 exposure to BAC. After repeated exposure to BAC formulation S. aureus showed a 222 significantly decreased susceptibility to ciprofloxacin (Table 1) .
223
Chlorhexidine. S. aureus showed a significant decrease in susceptibility to ampicillin 224 and ciprofloxacin after CHX exposure as well as an increase in susceptibility to tetracycline 225 (Table 1 ). E. coli demonstrated increased susceptibility to ciprofloxacin and ampicillin after 226 repeated exposure to chlorhexidine.
227
Didecydimethyl ammonium chloride. After exposure to DDAC, A. baumanii 228 showed a significant increase in susceptibility to ciprofloxacin and kanamycin and decreased 229 susceptibility to tetracycline when compared to the bacterium before microbicide exposure 230 (Table 1) . Increased susceptibility to ciprofloxacin, kanamycin and cephalothin was observed 231 for the E. coli drain isolate, whilst a significant reduction in tetracycline susceptibility was 232 also evident in this bacterium. After exposure to DDAC in formulation, the E. coli drain 233 isolate underwent a significant reduction in kanamycin, cephalothin, tetracycline and 234 ampicillin susceptibility, and an increase in susceptibility to ciprofloxacin. P. aeruginosa 235 showed a significant increase in ciprofloxacin susceptibility after long-term exposure to 236 DDAC formulation (Table 1) .
237
DMDM hydantoin. After repeated exposure to DMDM hydantoin the E. coli drain 238 isolate demonstrated a significant reduction in ciprofloxacin, kanamycin, cephalothin and 239 ampicillin susceptibility and an increase in tetracycline susceptibility when compared to its 240 pre-exposed counterpart (Table 1) .
Polyhexamethylene biguanide. Following adaptation to PHMB, the E. coli drain 242 isolate exhibited a decrease in kanamycin and ciprofloxacin susceptibility (Table 1) . S. aureus 243 developed a significantly reduced susceptibility to ampicillin and ciprofloxacin after repeated 244 PHMB exposure but higher tetracycline susceptibility when compared to the unexposed 245 parent strain. After exposure to PHMB formulation S. aureus also showed a significant 246 reduction in ciprofloxacin susceptibility. (Table 1) , whilst E. coli showed significant 251 increases in ciprofloxacin and cephalothin susceptibility but decreases in susceptibility to 252 kanamycin and tetracycline. A. baumanii increased in susceptibility to ciprofloxacin, 253 kanamycin and tetracycline compared to its unexposed counterpart (Table 1) .
254
Triclosan. Following exposure to triclosan, S. aureus exhibited significant reductions 255 in ciprofloxacin and ampicillin susceptibility whilst susceptibility to kanamycin, tetracycline 256 and cephalothin increased (Table 1 ). E. coli showed increased susceptibility to ampicillin and 257 ciprofloxacin for this bacterium after triclosan exposure, whilst the E. coli drain isolate 258 showed decreased ciprofloxacin susceptibility but increased cephalothin susceptibility, when 259 compared to the parent strain. Comparatively C. sakazakii showed a significant increase in 260 ciprofloxacin, cephalothin and kanamycin susceptibility, and a decrease in ampicillin 261 susceptibility after repeated triclosan exposure (Table 1) .
262
To gain an overview of the statistical significance of the observed changes in antibiotic 263 susceptibility and ask whether it was possible to identify consistent patterns in susceptibility, 264 linear mixed-effects models were fitted for how the susceptibility to particular antibiotics 265 varied, dependent on the antibiotic in question, the bacterium and the microbicidal 266 environment previously adapted to. A highly significant interaction (F 40, 298 = 15, P < 2 x 10 -267 16 ) indicative of different responses to particular antibiotics dependent on the microbicidal 268 environment to which the organism had previously adapted (Fig. 1) although that did not vary significantly among the antibiotics (F 8, 145 = 0.70, P = 0.69). The 285 effect of formulation was specific to BAC, with formulation giving a small increase in the 286 antibiotic susceptibility of microbes adapted to it (Fig. 2) . formulations reflecting application in the real world (24, 33) . This highlights the value of risk 300 assessments that more accurately reflect the way microbicides are deployed. In the current 301 investigation we have evaluated whether the formulation of microbicides additionally 302 mitigates the development of antibiotic insusceptibility in bacteria.
303
In order to investigate whether the formulation of microbicides affects cross-resistance to 304 antibiotics, we studied the induction of changes in antibiotic susceptibility in bacteria that had 305 been repeatedly exposed, using a highly selective system arguably representing a worst case 306 scenario, to microbicides in simple aqueous solution and in formulation with ingredients that 307 are used in consumer products such as laundry detergents, hard surface disinfectants and 308 personal care products (24). It should be noted that whilst the majority of microbicides tested 309 are widely used in domestic cleaning products, the use of triclosan in Europe is generally 310 restricted to applications where its utility is greatest, such as oral care.
311
Out of 288 microbicide-exposed bacteria, 28 organisms previously demonstrated a ≥4-fold 312 decrease in microbicide susceptibility (18 organisms adapted to microbicides following 313 exposure to simple aqueous solutions and 10 to microbicides in formulation). These were 314 further evaluated for changes in antibiotic susceptibility in the current study. The difference in the numbers of test bacteria between treatment groups results from the mitigating effects that 316 the formulation of microbicides had on the development of microbicide insusceptibility.
317
Increases in antibiotic susceptibility occurred at higher frequency following exposure to 318 simple solutions in comparison to formulations (20% v 12%) whilst 22% became significantly 319 less susceptible to the antibiotics regardless of formulation. Whilst both increases and 320 decreases in antibiotic susceptibility were observed in the test bacteria after exposure to 321 microbicide/formulation, no bacterium became resistant according to published BSAC 322 breakpoints.
323
Changes in antibiotic susceptibility varied between the test antibiotics, bacteria and the 324 microbicides that the bacteria had been previously adapted to, suggesting little correlative 325 effect between the different variables. One positive correlation was however observed 326 between the β-lactam antibiotics ampicillin and cephalothin (Table 2 ). In this case, 327 microbicide exposure could have altered alteration transpeptidase expression or otherwise 328 influenced cell wall permeability, subsequently impacting on the efficacy of these antibiotics 329 which target cell wall synthesis.
330
In some cases, bacterial antibiotic susceptibility was increased following microbicide 331 exposure. It is notable that such "cross-susceptibility" was associated with adaptation to at 332 least some microbicides for all antibiotics except ampicillin (Fig. 1) . The phenomenon of 333 "cross-susceptibility" has been observed in several previous investigations (17, 22, 34, 35) 334 where links between antibiotics and decreased microbicide susceptibility in bacteria have 335 been demonstrated in vitro (14, 17) . In a recent study, exposure of Burkholderia cepacia to 336 low concentrations of either CHX or BAC resulted in variable reductions in antibiotic 337 susceptibility (36). CHX exposure was reportedly associated with significant decreases in 338 susceptibility to ceftazidime, ciprofloxacin and imipenem, whilst short-term exposure to BAC 339 resulted in significant decreases in ceftazidime, ciprofloxacin and meropenem susceptibility.
340
These effects were however highly variable between biological replicates in a manner 341 suggestive of stochastic effects. In another recent investigation, six S. aureus strains including 342 methicillin-resistant S. aureus were repeatedly exposed to triclosan. Susceptibility to triclosan 343 was significantly decreased in all exposed bacteria, whereas antibiotic susceptibility was 344 significantly increased in the majority of cases. Whilst the reasons for cross-susceptibility 345 have not been elucidated, they are likely to include general fitness costs of adaptation and 346 transient cellular damage as previously hypothesized (37).
347
Mechanisms of cross-resistance have been more extensively investigated and include non- any changes in susceptibility to the aminoglycoside antibiotic kanamycin in bacteria that had 357 previously shown reduced susceptibility to both CHX and PHMB. However, we found no 358 evidence of a systematic effect of this sort (indeed adaptation to CHX typically led to an 359 increase in susceptibility to kanamycin; Fig. 1 ) and only the PHMB adapted E. coli drain 360 isolate showed any significant reduction in antibiotic susceptibility (Table 1) .
361
Cross-resistance between quaternary ammonium compounds (QACs), such as BAC and Triclosan exposure may select for mutations in the target enzyme fabI, an enoyl-acyl carrier 381 protein reductase that participates in bacterial fatty acid synthesis (45). There has been 382 concern over the induction of cross-resistance between triclosan and therapeutic agents that 383 also share this target enzyme, such as isoniazid used to treat Mycobacterium tuberculosis. 384 Cross-resistance between triclosan and certain antibiotics has been reported in P. aeruginosa 385 and is largely believed to be due to increased expression of the MexAB-OprM efflux system 386 (14). In the current investigation, data show reductions in ciprofloxacin susceptibility in S. 387 aureus and the E. coli drain isolate together with reductions in ampicillin susceptibility in S. 388 aureus and C. sakazakii after repeated triclosan exposure, which may potentially be mediated 389 through regulation of efflux or cell permeability.
390
Whilst the induction of cross-resistance between microbicides and antibiotics has been 391 previously investigated, little information is available concerning any effect of incorporation 392 of microbicides into formulations containing surfactants and sequestrants on antibiotic 393 susceptibility in adapted bacteria. Data presented here indicate that both decreases and 394 increases in antibiotic susceptibility can occur in bacteria following exposure to microbicides 395 in simple solution and in formulations using a highly selective system. A rigorous statistical 396 analysis demonstrated that formulation significantly affected the development of cross-397 resistance but that this was variable with the only consistently identified formulation effect 398 being a small increase in susceptibility across antibiotics in strains adapted to the formulated, 399 relative to the unformulated version of the microbicide benzalkonium chloride.
400
In conclusion, whilst both increases and decreases in antibiotic susceptibility were observed in 401 microbicide and formulation adapted bacteria, these were not sufficient to confer clinical 402 resistance according to published BSAC breakpoints. Table 1 . Antibiotic susceptibility of bacterial isolates that showed a ≥ 4-fold decrease in microbicide/formulation susceptibility following exposure to microbicides in simple aqueous solution or formulated with surfactants and sequestrants. Data show growth inhibition zones (mm) representative of antibiotic susceptibility before (P0) and after 14 passages (P14) in the presence of microbicide/formulation. Antibiotic zones of inhibition were determined before antimicrobial exposure (unexposed; UE) and after antimicrobial exposure to both unformulated (UF) (i.e. simple aqueoussolution) and formulated (F) (i.e. with surfactants and sequestrants) microbicides. †, non-drain isolates; *, drain isolates. Statistically significant changes are bold text (P < 0.05). Bacteria that did not undergo a ≥4-fold change in MBC were not assessed for changes in antibiotic susceptibility. Where data varied between biological replicates, standard deviations have been given in parentheses (n=6). Combinations of bacterium and antibiotic for which BSAC breakpoints are available are indicated in blue text. According to these, no susceptible bacterium became antibiotic resistant following microbicide adaptation. A value of 1 indicates that all organisms respond in a perfectly correlated way to the two antibiotics indicated (either more or less sensitive to both), a value of -1 would indicate a perfect negative correlation with organisms that are more sensitive to one antibiotic. Amp, ampicillin; cep, cephalothin; cip, ciprofloxacin; kan, kanamycin; tet, tetracycline.
